• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Liposomes Drug Delivery Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 116 Pages
  • Report Code: 24LS-21378
  • Formate :   
Download FREE Report Sample Download PDF File

Liposomes Drug Delivery -MARKET ADVISORY SERVICES

Liposomes Drug Delivery market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Liposomes Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.


Segment by Type, the Liposomes Drug Delivery market is segmented into

  • Liposomal Doxorubicin
  • Liposomal Amphoteracin B
  • Liposomal Paclitaxel
  • Others


Segment by Application, the Liposomes Drug Delivery market is segmented into

  • Fungal Infection Therapy
  • Cancer & Tumor Therapy
  • Others


Regional and Country-level Analysis:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA


Competitive Landscape and Liposomes Drug Delivery Market Share Analysis
Liposomes Drug Delivery market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Liposomes Drug Delivery product introduction, recent developments, Liposomes Drug Delivery sales by region, type, application and by sales channel.

The major companies include:

  • Gilead Sciences
  • Pacira
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Luye Pharma
  • Sigma-Tau Group
  • Ipsen (Onivyde)
  • CSPC
  • Teva Pharmaceutical
  • Novartis
  • Fudan-Zhangjiang
1 Study Coverage
1.1 Liposomes Drug Delivery Product Introduction
1.2 Market by Type
1.2.1 Global Liposomes Drug Delivery Market Size Growth Rate by Type
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposomes Drug Delivery Market Size Growth Rate by Application
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Liposomes Drug Delivery Market Size Estimates and Forecasts
2.1.1 Global Liposomes Drug Delivery Revenue 2015-2026
2.1.2 Global Liposomes Drug Delivery Sales 2015-2026
2.2 Liposomes Drug Delivery Market Size by Region: 2020 Versus 2026
2.3 Liposomes Drug Delivery Sales by Region (2015-2026)
2.3.1 Global Liposomes Drug Delivery Sales by Region: 2015-2020
2.3.2 Global Liposomes Drug Delivery Sales Forecast by Region (2021-2026)
2.3.3 Global Liposomes Drug Delivery Sales Market Share by Region (2015-2026)
2.4 Liposomes Drug Delivery Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Liposomes Drug Delivery Revenue by Region: 2015-2020
2.4.2 Global Liposomes Drug Delivery Revenue Forecast by Region (2021-2026)
2.4.3 Global Liposomes Drug Delivery Revenue Market Share by Region (2015-2026)

3 Global Liposomes Drug Delivery by Manufacturers
3.1 Global Top Liposomes Drug Delivery Manufacturers by Sales
3.1.1 Global Liposomes Drug Delivery Sales by Manufacturer (2015-2020)
3.1.2 Global Liposomes Drug Delivery Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Liposomes Drug Delivery Manufacturers by Revenue
3.2.1 Global Liposomes Drug Delivery Revenue by Manufacturer (2015-2020)
3.2.2 Global Liposomes Drug Delivery Revenue Share by Manufacturer (2015-2020)
3.3 Global Liposomes Drug Delivery Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Liposomes Drug Delivery Manufacturers Covered: Ranking by Revenue
3.4.2 Global Liposomes Drug Delivery Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Liposomes Drug Delivery Manufacturing Base Distribution, Product Type
3.5.1 Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Liposomes Drug Delivery Product Type
3.5.3 Date of International Manufacturers Enter into Liposomes Drug Delivery Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 Gilead Sciences
4.1.1 Gilead Sciences Corporation Information
4.1.2 Gilead Sciences Description, Business Overview
4.1.3 Gilead Sciences Liposomes Drug Delivery Products Offered
4.1.4 Gilead Sciences Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Gilead Sciences Liposomes Drug Delivery Revenue by Product
4.1.6 Gilead Sciences Liposomes Drug Delivery Revenue by Application
4.1.7 Gilead Sciences Liposomes Drug Delivery Revenue by Geographic Area
4.1.8 Gilead Sciences Liposomes Drug Delivery Revenue by Sales Channel
4.1.9 Gilead Sciences Recent Development
4.2 Pacira
4.2.1 Pacira Corporation Information
4.2.2 Pacira Description, Business Overview
4.2.3 Pacira Liposomes Drug Delivery Products Offered
4.2.4 Pacira Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Pacira Liposomes Drug Delivery Revenue by Product
4.2.6 Pacira Liposomes Drug Delivery Revenue by Application
4.2.7 Pacira Liposomes Drug Delivery Revenue by Geographic Area
4.2.8 Pacira Liposomes Drug Delivery Revenue by Sales Channel
4.2.9 Pacira Recent Development
4.3 Sun Pharmaceutical
4.3.1 Sun Pharmaceutical Corporation Information
4.3.2 Sun Pharmaceutical Description, Business Overview
4.3.3 Sun Pharmaceutical Liposomes Drug Delivery Products Offered
4.3.4 Sun Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Product
4.3.6 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Application
4.3.7 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Geographic Area
4.3.8 Sun Pharmaceutical Liposomes Drug Delivery Revenue by Sales Channel
4.3.9 Sun Pharmaceutical Recent Development
4.4 Johnson & Johnson
4.4.1 Johnson & Johnson Corporation Information
4.4.2 Johnson & Johnson Description, Business Overview
4.4.3 Johnson & Johnson Liposomes Drug Delivery Products Offered
4.4.4 Johnson & Johnson Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Johnson & Johnson Liposomes Drug Delivery Revenue by Product
4.4.6 Johnson & Johnson Liposomes Drug Delivery Revenue by Application
4.4.7 Johnson & Johnson Liposomes Drug Delivery Revenue by Geographic Area
4.4.8 Johnson & Johnson Liposomes Drug Delivery Revenue by Sales Channel
4.4.9 Johnson & Johnson Recent Development
4.5 Luye Pharma
4.5.1 Luye Pharma Corporation Information
4.5.2 Luye Pharma Description, Business Overview
4.5.3 Luye Pharma Liposomes Drug Delivery Products Offered
4.5.4 Luye Pharma Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Luye Pharma Liposomes Drug Delivery Revenue by Product
4.5.6 Luye Pharma Liposomes Drug Delivery Revenue by Application
4.5.7 Luye Pharma Liposomes Drug Delivery Revenue by Geographic Area
4.5.8 Luye Pharma Liposomes Drug Delivery Revenue by Sales Channel
4.5.9 Luye Pharma Recent Development
4.6 Sigma-Tau Group
4.6.1 Sigma-Tau Group Corporation Information
4.6.2 Sigma-Tau Group Description, Business Overview
4.6.3 Sigma-Tau Group Liposomes Drug Delivery Products Offered
4.6.4 Sigma-Tau Group Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Sigma-Tau Group Liposomes Drug Delivery Revenue by Product
4.6.6 Sigma-Tau Group Liposomes Drug Delivery Revenue by Application
4.6.7 Sigma-Tau Group Liposomes Drug Delivery Revenue by Geographic Area
4.6.8 Sigma-Tau Group Recent Development
4.7 Ipsen (Onivyde)
4.7.1 Ipsen (Onivyde) Corporation Information
4.7.2 Ipsen (Onivyde) Description, Business Overview
4.7.3 Ipsen (Onivyde) Liposomes Drug Delivery Products Offered
4.7.4 Ipsen (Onivyde) Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Ipsen (Onivyde) Liposomes Drug Delivery Revenue by Product
4.7.6 Ipsen (Onivyde) Liposomes Drug Delivery Revenue by Application
4.7.7 Ipsen (Onivyde) Liposomes Drug Delivery Revenue by Geographic Area
4.7.8 Ipsen (Onivyde) Recent Development
4.8 CSPC
4.8.1 CSPC Corporation Information
4.8.2 CSPC Description, Business Overview
4.8.3 CSPC Liposomes Drug Delivery Products Offered
4.8.4 CSPC Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.8.5 CSPC Liposomes Drug Delivery Revenue by Product
4.8.6 CSPC Liposomes Drug Delivery Revenue by Application
4.8.7 CSPC Liposomes Drug Delivery Revenue by Geographic Area
4.8.8 CSPC Recent Development
4.9 Teva Pharmaceutical
4.9.1 Teva Pharmaceutical Corporation Information
4.9.2 Teva Pharmaceutical Description, Business Overview
4.9.3 Teva Pharmaceutical Liposomes Drug Delivery Products Offered
4.9.4 Teva Pharmaceutical Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Product
4.9.6 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Application
4.9.7 Teva Pharmaceutical Liposomes Drug Delivery Revenue by Geographic Area
4.9.8 Teva Pharmaceutical Recent Development
4.10 Novartis
4.10.1 Novartis Corporation Information
4.10.2 Novartis Description, Business Overview
4.10.3 Novartis Liposomes Drug Delivery Products Offered
4.10.4 Novartis Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Novartis Liposomes Drug Delivery Revenue by Product
4.10.6 Novartis Liposomes Drug Delivery Revenue by Application
4.10.7 Novartis Liposomes Drug Delivery Revenue by Geographic Area
4.10.8 Novartis Recent Development
4.11 Fudan-Zhangjiang
4.11.1 Fudan-Zhangjiang Corporation Information
4.11.2 Fudan-Zhangjiang Description, Business Overview
4.11.3 Fudan-Zhangjiang Liposomes Drug Delivery Products Offered
4.11.4 Fudan-Zhangjiang Liposomes Drug Delivery Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Product
4.11.6 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Application
4.11.7 Fudan-Zhangjiang Liposomes Drug Delivery Revenue by Geographic Area
4.11.8 Fudan-Zhangjiang Recent Development

5 Breakdown Data by Type
5.1 Global Liposomes Drug Delivery Sales by Type (2015-2026)
5.1.1 Global Liposomes Drug Delivery Sales by Type (2015-2020)
5.1.2 Global Liposomes Drug Delivery Sales Forecast by Type (2021-2026)
5.1.3 Global Liposomes Drug Delivery Sales Market Share by Type (2015-2026)
5.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2015-2026)
5.2.1 Global Liposomes Drug Delivery Revenue by Type (2015-2020)
5.2.2 Global Liposomes Drug Delivery Revenue Forecast by Type (2021-2026)
5.2.3 Global Liposomes Drug Delivery Revenue Market Share by Type (2015-2026)
5.3 Liposomes Drug Delivery Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Liposomes Drug Delivery Sales by Application (2015-2026)
6.1.1 Global Liposomes Drug Delivery Sales by Application (2015-2020)
6.1.2 Global Liposomes Drug Delivery Sales Forecast by Application (2021-2026)
6.1.3 Global Liposomes Drug Delivery Sales Market Share by Application (2015-2026)
6.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2015-2026)
6.2.1 Global Liposomes Drug Delivery Revenue by Application (2015-2020)
6.2.2 Global Liposomes Drug Delivery Revenue Forecast by Application (2021-2026)
6.2.3 Global Liposomes Drug Delivery Revenue Market Share by Application (2015-2026)
6.3 Liposomes Drug Delivery Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Liposomes Drug Delivery Market Size YoY Growth 2015-2026
7.2 North America Liposomes Drug Delivery Market Facts & Figures by Country
7.2.1 North America Liposomes Drug Delivery Sales by Country (2015-2026)
7.2.2 North America Liposomes Drug Delivery Revenue by Country (2015-2026)
7.3 North America Liposomes Drug Delivery Sales by Type
7.4 North America Liposomes Drug Delivery Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Liposomes Drug Delivery Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Liposomes Drug Delivery Market Facts & Figures by Region
8.2.1 Asia-Pacific Liposomes Drug Delivery Sales by Region (2015-2026)
8.2.2 Asia-Pacific Liposomes Drug Delivery Revenue by Region (2015-2026)
8.3 Asia-Pacific Liposomes Drug Delivery Sales by Type
8.4 Asia-Pacific Liposomes Drug Delivery Sales by Application
9 Europe
9.1 Europe Liposomes Drug Delivery Market Size YoY Growth 2015-2026
9.2 Europe Liposomes Drug Delivery Market Facts & Figures by Country
9.2.1 Europe Liposomes Drug Delivery Sales by Country (2015-2026)
9.2.2 Europe Liposomes Drug Delivery Revenue by Country (2015-2026)
9.3 Europe Liposomes Drug Delivery Sales by Type
9.4 Europe Liposomes Drug Delivery Sales by Application
10 Latin America
10.1 Latin America Liposomes Drug Delivery Market Size YoY Growth 2015-2026
10.2 Latin America Liposomes Drug Delivery Market Facts & Figures by Country
10.2.1 Latin America Liposomes Drug Delivery Sales by Country (2015-2026)
10.2.2 Latin America Liposomes Drug Delivery Revenue by Country (2015-2026)
10.3 Latin America Liposomes Drug Delivery Sales by Type
10.4 Latin America Liposomes Drug Delivery Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Liposomes Drug Delivery Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Liposomes Drug Delivery Market Facts & Figures by Country
11.2.1 Middle East and Africa Liposomes Drug Delivery Sales by Country (2015-2026)
11.2.2 Middle East and Africa Liposomes Drug Delivery Revenue by Country (2015-2026)
11.3 Middle East and Africa Liposomes Drug Delivery Sales by Type
11.4 Middle East and Africa Liposomes Drug Delivery Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Liposomes Drug Delivery Supply Chain Analysis
12.2 Liposomes Drug Delivery Key Raw Materials and Upstream Suppliers
12.3 Liposomes Drug Delivery Clients Analysis
12.4 Liposomes Drug Delivery Sales Channel and Sales Model Analysis
12.4.1 Liposomes Drug Delivery Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Liposomes Drug Delivery Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Liposomes Drug Delivery Distributors
13 Market Dynamics
13.1 Liposomes Drug Delivery Market Drivers
13.2 Liposomes Drug Delivery Market Opportunities
13.3 Liposomes Drug Delivery Market Challenges
13.4 Liposomes Drug Delivery Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Liposomes Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Liposomal Doxorubicin

Table 3. Major Manufacturers of Liposomal Amphoteracin B

Table 4. Major Manufacturers of Liposomal Paclitaxel

Table 5. Major Manufacturers of Others

Table 6. Global Liposomes Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 7. Global Liposomes Drug Delivery Market Size by Region (US$ Million): 2020 VS 2026

Table 8. Global Liposomes Drug Delivery Sales by Region (2015-2020) & (K Vial)

Table 9. Global Liposomes Drug Delivery Sales Forecast by Region (2021-2026) & (K Vial)

Table 10. Global Liposomes Drug Delivery Revenue by Region (2015-2020) & (US$ Million)

Table 11. Global Liposomes Drug Delivery Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 12. Global Liposomes Drug Delivery Sales by Manufacturer (2015-2020) & (K Vial)

Table 13. Global Liposomes Drug Delivery Sales Share by Manufacturer (2015-2020)

Table 14. Liposomes Drug Delivery Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 15. Liposomes Drug Delivery Revenue Share by Manufacturer (2015-2020)

Table 16. Key Manufacturers Liposomes Drug Delivery Price (2015-2020) & (USD/Vial)

Table 17. Ranking of Global Top Liposomes Drug Delivery Manufacturers by Revenue (US$ Million) in 2019

Table 18. Global Liposomes Drug Delivery Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 19. Global Liposomes Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposomes Drug Delivery as of 2019)

Table 20. Liposomes Drug Delivery Manufacturers Manufacturing Base Distribution and Headquarters

Table 21. Manufacturers Liposomes Drug Delivery Product Type

Table 22. Date of International Manufacturers Enter into Liposomes Drug Delivery Market

Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 24. Gilead Sciences Corporation Information

Table 25. Gilead Sciences Description and Business Overview

Table 26. Gilead Sciences Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 27. Gilead Sciences Liposomes Drug Delivery Product

Table 28. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 29. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 30. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 31. Gilead Sciences Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel

Table 32. Gilead Sciences Recent Development

Table 33. Pacira Corporation Information

Table 34. Pacira Description and Business Overview

Table 35. Pacira Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 36. Pacira Liposomes Drug Delivery Product

Table 37. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 38. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 39. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 40. Pacira Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel

Table 41. Pacira Recent Development

Table 42. Sun Pharmaceutical Corporation Information

Table 43. Sun Pharmaceutical Description and Business Overview

Table 44. Sun Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 45. Sun Pharmaceutical Liposomes Drug Delivery Product

Table 46. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 47. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 48. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 49. Sun Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel

Table 50. Sun Pharmaceutical Recent Development

Table 51. Johnson & Johnson Corporation Information

Table 52. Johnson & Johnson Description and Business Overview

Table 53. Johnson & Johnson Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 54. Johnson & Johnson Liposomes Drug Delivery Product

Table 55. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 56. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 57. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 58. Johnson & Johnson Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel

Table 59. Johnson & Johnson Recent Development

Table 60. Luye Pharma Corporation Information

Table 61. Luye Pharma Description and Business Overview

Table 62. Luye Pharma Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 63. Luye Pharma Liposomes Drug Delivery Product

Table 64. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 65. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 66. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 67. Luye Pharma Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Sales Channel

Table 68. Luye Pharma Recent Development

Table 69. Sigma-Tau Group Corporation Information

Table 70. Sigma-Tau Group Description and Business Overview

Table 71. Sigma-Tau Group Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 72. Sigma-Tau Group Liposomes Drug Delivery Product

Table 73. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 74. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 75. Sigma-Tau Group Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 76. Sigma-Tau Group Recent Development

Table 77. Ipsen (Onivyde) Corporation Information

Table 78. Ipsen (Onivyde) Description and Business Overview

Table 79. Ipsen (Onivyde) Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 80. Ipsen (Onivyde) Liposomes Drug Delivery Product

Table 81. Ipsen (Onivyde) Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 82. Ipsen (Onivyde) Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 83. Ipsen (Onivyde) Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 84. Ipsen (Onivyde) Recent Development

Table 85. CSPC Corporation Information

Table 86. CSPC Description and Business Overview

Table 87. CSPC Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 88. CSPC Liposomes Drug Delivery Product

Table 89. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 90. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 91. CSPC Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 92. CSPC Recent Development

Table 93. Teva Pharmaceutical Corporation Information

Table 94. Teva Pharmaceutical Description and Business Overview

Table 95. Teva Pharmaceutical Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 96. Teva Pharmaceutical Liposomes Drug Delivery Product

Table 97. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 98. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 99. Teva Pharmaceutical Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 100. Teva Pharmaceutical Recent Development

Table 101. Novartis Corporation Information

Table 102. Novartis Description and Business Overview

Table 103. Novartis Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 104. Novartis Liposomes Drug Delivery Product

Table 105. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 106. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 107. Novartis Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 108. Novartis Recent Development

Table 109. Fudan-Zhangjiang Corporation Information

Table 110. Fudan-Zhangjiang Description and Business Overview

Table 111. Fudan-Zhangjiang Liposomes Drug Delivery Sales (K Vial), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2015-2020)

Table 112. Fudan-Zhangjiang Liposomes Drug Delivery Product

Table 113. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Product

Table 114. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Application

Table 115. Fudan-Zhangjiang Liposomes Drug Delivery Revenue (US$ Million) and Market Share by Geographic Area

Table 116. Fudan-Zhangjiang Recent Development

Table 117. Global Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 118. Global Liposomes Drug Delivery Sales Forecast by Type (2021-2026) & (K Vial)

Table 119. Global Liposomes Drug Delivery Revenue by Type (2015-2020) & (US$ Million)

Table 120. Global Liposomes Drug Delivery Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 121. Global Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 122. Global Liposomes Drug Delivery Sales Forecast by Application (2021-2026) & (K Vial)

Table 123. Global Liposomes Drug Delivery Revenue by Application (2015-2020) & (US$ Million)

Table 124. Global Liposomes Drug Delivery Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 125. North America Liposomes Drug Delivery Sales by Country (2015-2020) & (K Vial)

Table 126. North America Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vial)

Table 127. North America Liposomes Drug Delivery Revenue by Country (2015-2020) & (US$ Million)

Table 128. North America Liposomes Drug Delivery Revenue by Country (2021-2026) & (US$ Million)

Table 129. North America Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 130. North America Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 131. Asia-Pacific Liposomes Drug Delivery Sales by Region (2015-2020) & (K Vial)

Table 132. Asia-Pacific Liposomes Drug Delivery Sales by Region (2021-2026) & (K Vial)

Table 133. Asia-Pacific Liposomes Drug Delivery Revenue by Region (2015-2026) & (US$ Million)

Table 134. Asia-Pacific Liposomes Drug Delivery Revenue by Region (2021-2026) & (US$ Million)

Table 135. Asia-Pacific Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 136. Asia-Pacific Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 137. Europe Liposomes Drug Delivery Sales by Country (2015-2020) & (K Vial)

Table 138. Europe Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vial)

Table 139. Europe Liposomes Drug Delivery Revenue by Country (2015-2020) & (US$ Million)

Table 140. Europe Liposomes Drug Delivery Revenue by Country (2021-2026) & (US$ Million)

Table 141. Europe Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 142. Europe Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 143. Latin America Liposomes Drug Delivery Sales by Country (2015-2020) & (K Vial)

Table 144. Latin America Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vial)

Table 145. Latin America Liposomes Drug Delivery Revenue by Country (2015-2020) & (US$ Million)

Table 146. Latin America Liposomes Drug Delivery Revenue by Country (2021-2026) & (US$ Million)

Table 147. Latin America Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 148. Latin America Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 149. Middle East and Africa Liposomes Drug Delivery Sales by Country (2015-2020) & (K Vial)

Table 150. Middle East and Africa Liposomes Drug Delivery Sales by Country (2021-2026) & (K Vial)

Table 151. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2015-2020) & (US$ Million)

Table 152. Middle East and Africa Liposomes Drug Delivery Revenue by Country (2021-2026) & (US$ Million)

Table 153. Middle East and Africa Liposomes Drug Delivery Sales by Type (2015-2020) & (K Vial)

Table 154. Middle East and Africa Liposomes Drug Delivery Sales by Application (2015-2020) & (K Vial)

Table 155. Liposomes Drug Delivery Key Raw Materials, Industry Status and Trend

Table 156. Liposomes Drug Delivery Key Raw Materials and Upstream Suppliers

Table 157. Liposomes Drug Delivery Clients Status and Trend

Table 158. Liposomes Drug Delivery Typical Clients

Table 159. Liposomes Drug Delivery Distributors

Table 160. Key Drivers: Impact Analysis (2021-2026)

Table 161. Liposomes Drug Delivery Market Drivers

Table 162. Liposomes Drug Delivery Market Opportunities

Table 163. Liposomes Drug Delivery Market Challenges

Table 164. Liposomes Drug Delivery Market Restraints

Table 165. Liposomes Drug Delivery Porter?s Five Forces Analysis

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Liposomes Drug Delivery Product Picture

Figure 2. Global Liposomes Drug Delivery Sales Market Share by Type in 2020 & 2026

Figure 3. Liposomal Doxorubicin Product Picture

Figure 4. Liposomal Amphoteracin B Product Picture

Figure 5. Liposomal Paclitaxel Product Picture

Figure 6. Others Product Picture

Figure 7. Global Liposomes Drug Delivery Sales Market Share by Application in 2020 & 2026

Figure 8. Fungal Infection Therapy Examples

Figure 9. Cancer & Tumor Therapy Examples

Figure 10. Others Examples

Figure 11. Liposomes Drug Delivery Report Years Considered

Figure 12. Global Liposomes Drug Delivery Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 13. Global Liposomes Drug Delivery Market Size 2015-2026 (US$ Million)

Figure 14. Global Liposomes Drug Delivery Sales 2015-2026 (K Units)

Figure 15. Global Liposomes Drug Delivery Market Size Market Share by Region: 2020 Versus 2026

Figure 16. Global Liposomes Drug Delivery Sales Market Share Forecast by Region (2015-2026)

Figure 17. Global Liposomes Drug Delivery Revenue Market Share by Region (2015-2026)

Figure 18. Global Liposomes Drug Delivery Sales Share by Manufacturer in 2019

Figure 19. Liposomes Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 20. Global Liposomes Drug Delivery Sales Market Share Forecast by Type (2015-2026)

Figure 21. Global Liposomes Drug Delivery Revenue Market Share Forecast by Type (2015-2026)

Figure 22. Liposomes Drug Delivery Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 23. Global Liposomes Drug Delivery Sales Market Share Forecast by Application (2015-2026)

Figure 24. Global Liposomes Drug Delivery Revenue Market Share Forecast by Application (2015-2026)

Figure 25. Liposomes Drug Delivery Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 26. North America Liposomes Drug Delivery Revenue 2015-2026 (US$ Million)

Figure 27. North America Liposomes Drug Delivery Sales Market Share by Type (2015-2020)

Figure 28. North America Liposomes Drug Delivery Sales Market Share by Application (2015-2020)

Figure 29. Asia-Pacific Liposomes Drug Delivery Revenue 2015-2026 (US$ Million)

Figure 30. Asia-Pacific Liposomes Drug Delivery Sales Market Share by Region (2015-2026)

Figure 31. Asia-Pacific Liposomes Drug Delivery Revenue Market Share by Region (2015-2026)

Figure 32. Asia-Pacific Liposomes Drug Delivery Sales Market Share by Type (2015-2020)

Figure 33. Asia-Pacific Liposomes Drug Delivery Sales Market Share by Application (2015-2020)

Figure 34. Europe Liposomes Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)

Figure 35. Europe Liposomes Drug Delivery Sales Market Share by Country (2015-2026)

Figure 36. Europe Liposomes Drug Delivery Revenue Market Share by Country (2015-2026)

Figure 37. Europe Liposomes Drug Delivery Sales Market Share by Type (2015-2020)

Figure 38. Europe Liposomes Drug Delivery Sales Market Share by Application (2015-2020)

Figure 39. Latin America Liposomes Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)

Figure 40. Latin America Liposomes Drug Delivery Sales Market Share by Country (2015-2026)

Figure 41. Latin America Liposomes Drug Delivery Revenue Market Share by Country (2015-2020)

Figure 42. Latin America Liposomes Drug Delivery Sales Market Share by Type (2015-2020)

Figure 43. Latin America Liposomes Drug Delivery Sales Market Share by Application (2015-2020)

Figure 44. Middle East and Africa Liposomes Drug Delivery Revenue Growth Rate 2015-2026 (US$ Million)

Figure 45. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Country (2015-2026)

Figure 46. Middle East and Africa Liposomes Drug Delivery Revenue Market Share by Country (2015-2026)

Figure 47. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Type (2015-2020)

Figure 48. Middle East and Africa Liposomes Drug Delivery Sales Market Share by Application (2015-2020)

Figure 49. Liposomes Drug Delivery Supply Chain (Upstream and Downstream Market)

Figure 50. Global Production Market Share of Liposomes Drug Delivery Raw Materials by Region in 2019

Figure 51. Liposomes Drug Delivery Distribution Channels

Figure 52. Global Liposomes Drug Delivery Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 53. Global Liposomes Drug Delivery Percentage 2015-2026: Online Sales VS Offline Sales

Figure 54. Porter's Five Forces Analysis

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Gilead Sciences

Pacira

Sun Pharmaceutical

Johnson & Johnson

Luye Pharma

Sigma-Tau Group

Ipsen (Onivyde)

CSPC

Teva Pharmaceutical

Novartis

Fudan-Zhangjiang

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4602

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase